Enclomisign
Enclomiphene tablets for low testosterone due to secondary hypogonadism. They stimulate the body's own testosterone production.
- Categories
- Women's Health · Hormone Therapy
- Active ingredient
- Enclomiphene
- Route
- Oral use
- Form
- Tablet
- Strengths
- 50mg
Prescription and consultation requirements for Enclomisign vary by destination and are determined by the fulfilment partner.
Enclomisign details
- Condition
- Secondary Hypogonadism
- Alternative names
- enclomiphene
- Therapeutic class
- Selective Oestrogen Receptor Modulator (SERM)
- Pharmacological class
- Oestrogen Antagonist
- Known off-label uses
- male infertility
- Contraindications
- pregnancy; liver disease; ovarian cysts; unexplained abnormal bleeding
- Minor side effects
- hot flushes; headache; nausea
- Moderate side effects
- ovarian enlargement; ovarian hyperstimulation; joint pain
- Serious side effects
- deep vein thrombosis, requires immediate medical attention
- Dosage forms
- Tablet
- Administration route
- Oral use
- Supply category
- Prescription-only medicine (POM)
- Manufacturer
- Signature Pharma
- Onset Time
- 5–10 days
- Duration
- 5 days
- Storage instructions
- Store below 25°C.
- Drug interactions
- Oestrogens
- Age restrictions
- Approved for adult females of childbearing age.
Patient summary
Enclomiphene tablets for low testosterone due to secondary hypogonadism. They stimulate the body's own testosterone production.
Mechanism of action
Blocks oestrogen feedback loops at the hypothalamus, triggering increased gonadotropin release to stimulate ovarian follicle maturation.
Pregnancy and breastfeeding
Pregnancy: Highly contraindicated during pregnancy. Breastfeeding: May inhibit milk production.